The world of medical care seems obsessed with only one thing at the moment. The c word that is not cancer.
But beyond the immediate global healthcare challenge of the pandemic technological forces are fundamentally altering the shape of medical care and the interface between flesh and chips grows ever closer.
Elon Musk’s Neuralink, the company developing microchips designed to go in people’s brains, raised R2.9 billion in funding, recently.
While a lesser known competitor is actually further down the line in commercialising this technology.
New York-based Synchron revealed on July 28th that it received permission from the Food and Drug Administration in the US to test its device in human patients.
The trial, known as an early feasibility study, is essential to proving the implants work safely and could one day be sold in the U.S.
What does all of this mean for the way we access healthcare, the cost of healthcare and of course the fundamental questions, of what it means to be human. To find out I’m joined now by Jaishree Naidoo Paediatric Radiologist and CEO of Envisionit Deep AI & J Johan Steyn, Lead Architect: Automation at PwC South Africa
